EDGAR Filing Documents for 0001047469-18-007114

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001047469-18-007114

Filing Date

2018-11-07

Accepted

2018-11-07 16:55:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	F-3	a2237074zf-3.htm	F-3	427329
2	EX-1.2	a2237074zex-1_2.htm	EX-1.2	291127
3	EX-5.1	a2237074zex-5_1.htm	EX-5.1	47030
4	EX-5.2	a2237074zex-5_2.htm	EX-5.2	14528
5	EX-5.3	a2237074zex-5_3.htm	EX-5.3	49473
6	EX-23.1	a2237074zex-23_1.htm	EX-23.1	3286
7	G402589.JPG	g402589.jpg	GRAPHIC	16525
8	G267880.JPG	g267880.jpg	GRAPHIC	10638
	Complete submission text file	0001047469-18-007114.txt		871458

Mailing Address DARWINWEG 24 LEIDEN P7 2333CR

Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000

ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-228251 | Film No.: 181167084
SIC: 2834 Pharmaceutical Preparations